Table 2 Lymphocyte subsets in peripheral blood versus tumor tissue (n = 34)

Gran %CD45

3.24 ± 5.72

10.55 ± 12.71

0.002

T %MNC

55.59 ± 12.03

68.58 ± 17.81

< 0.001

CD4%T

54.04 ± 13.18

45.85 ± 14.49

0.013

CD8%T

32.37 ± 11.22

44.92 ± 13.98

< 0.001

CD4:CD8

1.94 ± 0.94

1.22 ± 0.74

0.001

rdT %T

7.53 ± 4.57

2.68 ± 1.77

0.001

B % MNC

5.93 ± 2.92

5.00 ± 3.44

0.302^#

pDC % MNC

0.24 ± 0.13

0.67 ± 0.79

0.003

CD11c + % pDC

8.13 ± 5.08

5.90 ± 4.74

0.109^#

Baso % MNC

0.83 ± 0.50

0.09 ± 0.16

< 0.001

BDCA1+ mDC % MNC

0.37 ± 0.17

0.11 ± 0.14

< 0.001

BDCA3+ mDC % MNC

0.02 ± 0.04

0.02 ± 0.06

1.000^#

Mono % MNC

16.69 ± 9.38

8.66 ± 8.29

< 0.001

CD14+ Mo % MNC

14.76 ± 7.03

2.28 ± 2.34

< 0.001

CD16+ Mo % MNC

3.27 ± 2.25

5.85 ± 5.75

0.036

CD16+ %Mono

18.45 ± 7.79

71.62 ± 13.20

< 0.001

NK %MNC

17.27 ± 9.83

5.88 ± 12.63

< 0.001

CD56hi NK % MNC

0.33 ± 0.16

4.38 ± 11.71

0.079^#

CD56lo NK % MNC

17.66 ± 9.97

1.24 ± 1.94

< 0.001

CD56hi %NK

2.42 ± 1.81

65.31 ± 23.69

< 0.001

MDSC % CD33hi

1.85 ± 3.50

2.39 ± 3.83

0.592^#

DR- %14 + APC

0.41 ± 1.50

18.13 ± 18.68

< 0.001

DR- %16 + APC

0.67 ± 1.08

1.64 ± 2.96

0.059^#